| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a661fce2db0dbce3e79acdcfb53cc9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f058b8e42d5225d4e1cdad4d177bb7cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 |
| filingDate |
2007-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46f2f6b71936610ba1eba51585246f27 |
| publicationDate |
2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8410173-B2 |
| titleOfInvention |
Inhibition of JAK2 as a treatment of pulmonary arterial hypertension |
| abstract |
The present invention relates to a method of treating pulmonary arterial hypertension by administering a therapeutically effective amount of a selective JAK2 inhibitor to a patient in need thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10953020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446313-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016145032-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10532994-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008267969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015352111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364238-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8563511-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9925184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10246438-B2 |
| priorityDate |
2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |